Virbac has launched Canergy, a new treatment designed to improve the demeanour and energy levels of older dogs.

Canergy contains propentofylline, a xanthine derivative which, Virbac says, potentiates the action of adenosine, a molecule found in the body which has a wide range of physiological effects which can be beneficial in the management of various age-related degenerative disease in dogs and cats1.

In particular, Virbac says propentofylline improves peripheral and cerebral vascular blood circulation, and has bronchodilating actions. This helps to increase oxygen supply to organs and muscles, which can result in a positive effect on overall demeanour and energy levels in older dogs.

Canergy is a beef-flavoured tablet which features SmartTab divisible design.

Canergy Product Manager Claire Lewis said: "Growing old should not have to be a barrier to enjoying life, so we are delighted to be able to add Canergy to the Virbac portfolio."

For more information, contact Virbac ob 01359 243243, email: enquiries@virbac.co.uk or visit: www.virbac.co.uk  

Reference

  1. R.J. Scaramuzzi, D.J. Baker, Possible Therapeutic benefits of adenosine-potentiating drugs in reducing age-related degenerative disease in dogs and cats, J. Vet Pharmacol. therap (2003); 26:327-335 

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.